Viewing Study NCT00333866


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-25 @ 2:04 PM
Study NCT ID: NCT00333866
Status: COMPLETED
Last Update Posted: 2021-02-11
First Post: 2006-06-02
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia.
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-07
Start Date Type: None
Primary Completion Date: 2007-11
Primary Completion Date Type: ACTUAL
Completion Date: 2007-11
Completion Date Type: ACTUAL
First Submit Date: 2006-06-02
First Submit QC Date: None
Study First Post Date: 2006-06-06
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2008-11-20
Results First Submit QC Date: None
Results First Post Date: 2009-05-13
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-01-26
Last Update Post Date: 2021-02-11
Last Update Post Date Type: ACTUAL